Research Communication: Comparative Effectiveness of Ustekinumab and Vedolizumab in the Management of Chronic Pouchitis—A Population‐Based Study
Our findings suggest that ustekinumab may offer advantages over vedolizumab in the management of chronic pouchitis.
Authors
- June Tome (ORCID: https://orcid.org/0000-0001-9914-1695)
- Darrell S. Pardi (ORCID: https://orcid.org/0000-0003-0420-8784)
- Francis A. Farraye (ORCID: https://orcid.org/0000-0001-6371-2441)
- Saqr Alsakarneh
Institutions
- Mayo Clinic (US)
- Jacksonville College (US)
- WinnMed (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-10-11
- DOI
- https://doi.org/10.1111/apt.70404
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00